iBio (IBIO) Other Working Capital Changes (2013 - 2026)
iBio (IBIO) posted quarterly Other Working Capital Changes of $189000.0 for Q1 2026, up 126.14% year-over-year from $83576.1 in Q1 2025, and up 200.0% quarter-over-quarter from -$189000.0 in Q4 2025.
iBio (IBIO) Other Working Capital Changes (2013 - 2026) Analysis & Trends
iBio (IBIO) has reported Other Working Capital Changes for 11 consecutive years, with $189000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 126.14% year-over-year to $189000.0; the TTM figure through Mar 2026 stood at $523000.0 (up 225.72% YoY), while the FY2025 annual figure was $250000.0, up 164.27% from the prior year.
- Other Working Capital Changes rose to $189000.0 in Q1 2026 per IBIO's latest filing, from -$189000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $1.3 million in Q4 2021 and bottomed at -$801000.0 in Q2 2022.
- Historically, Other Working Capital Changes has averaged -$45578.9 across 5 years, with a median of -$38000.0 in 2023.
- Annual changes were most pronounced in 2024 — Other Working Capital Changes tumbled 3466.67% — and 2025, when it surged 716.13%.
- iBio's Other Working Capital Changes stood at -$73000.0 in 2022, then plunged by 36.99% to -$100000.0 in 2023, then soared by 604.0% to $504000.0 in 2024, then slumped by 137.5% to -$189000.0 in 2025, then surged by 200.0% to $189000.0 in 2026.
- Business Quant data shows IBIO's Other Working Capital Changes at $189000.0 in Q1 2026, -$189000.0 in Q4 2025, and -$50000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.93 Bn | 131.07 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.91 Bn | 77.92 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.98 Bn | 59.80 Bn | 1.37 Bn |
| 4 | Moderna | 58.86 Bn | 53.72 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.88 Bn | 9.49 Bn | 668.28 Mn |
| 8 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.35 Bn | 26.51 Bn | - |
| 10 | iBio | 173.30 Mn | 173.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 189,000.00 |
| Mar 31, 2026 | 189,000.00 |
| Mar 31, 2026 | 189,000.00 |
| Dec 31, 2025 | -189,000.00 |
| Dec 31, 2025 | -189,000.00 |
| Dec 31, 2025 | -189,000.00 |
| Sep 30, 2025 | -50,000.00 |
| Sep 30, 2025 | -50,000.00 |
| Sep 30, 2025 | -50,000.00 |
| Jun 30, 2025 | 573,000.00 |
| Jun 30, 2025 | 573,000.00 |
| Jun 30, 2025 | 573,000.00 |
| Mar 31, 2025 | -723,000.00 |
| Mar 31, 2025 | -723,000.00 |
| Mar 31, 2025 | -723,000.00 |
| Dec 31, 2024 | 504,000.00 |
| Dec 31, 2024 | 504,000.00 |
| Dec 31, 2024 | 504,000.00 |
| Sep 30, 2024 | -104,000.00 |
| Sep 30, 2024 | -104,000.00 |